After completing the CME activity, learners should be better able to:
Recognize the importance of an early differential diagnosis of Alzheimer’s disease to allow for early disease management or referral
Describe current understanding of AD pathophysiology and review the use of cognitive and neuroimaging tests as part of a comprehensive evaluation for the early diagnosis of mild Alzheimer’s disease
Discuss current and emerging therapeutic targets, and new data on investigational agents for treatment of mild AD with a disease-modifying approach to delay or slow AD progression